ASA Monitor September 2024, Vol. 88, 30.
WHO prequalifies the first self-test for hepatitis C virus
The World Health Organization (WHO) has prequalified the first hepatitis C virus (HCV) self-test which can provide a critical support in expanding access to testing and diagnosis, accelerating global efforts to eliminate hepatitis C.
The product, called OraQuick HCV self-test, manufactured by OraSure Technologies, is an extension of the prequalified, OraQuick® HCV Rapid Antibody Test that was initially prequalified by WHO in 2017 for professional use.
“Everyday, 3,500 lives are lost to viral hepatitis. Of the 50 million people living with hepatitis C, only 36% had been diagnosed, and 20% have received curative treatment by the end of 2022,” says Dr. Meg Doherty, WHO Director for the Department of Global HIV, Hepatitis and STI Programmes. “The addition of this product to the WHO prequalification list provides a safe and effective way to expand HCV testing and treatment services, ensuring more people receive the diagnoses and treatment they need, and ultimately contributing to the global goal of HCV elimination.”
Source: asamonitor.pub/3xIAObo
Leave a Reply
You must be logged in to post a comment.